“…The reader is directed to other reviews on sex and gender differences in contribution to disease (Mielke et al, 2014). Indeed, disease progression and manifestation in a number of brain disorders may be influenced by levels of sex steroids (Amiaz and Seidman, 2008; Baum, 2005; Bloch et al, 2003; Lv et al, 2015; McIntyre et al, 2006; Moffat et al, 2004; Rosario et al, 2011; Sankar & Hampson, 2012). For example, lower levels of 17β-estradiol in women are associated with an increased incidence of neurological and neuropsychiatric diseases (Baum, 2005; Rosario et al, 2011; Wieck, 2011).…”